Atorvastatin tablets 10 mg, 20 mg, 40 mg and 80 mg
Atorvastatin is a medicine that is used to treat high cholesterol.
What is changing?
The brand of atorvastatin that PHARMAC funds will change from Zarator to Lorstat.
When will this change happen?
- From 1 September 2016 Lorstat will be fully funded.
- From 1 November 2016 a part payment may be required for Zarator. Lorstat will continue to be fully funded.
- From 1 February 2017 only Lorstat will be available fully funded. Zarator will no longer be funded.
Will the new brand work the same?
Yes. Only the brand of your medicine is changing. The newly funded tablets will have the same amount of the active ingredient, atorvastatin. This means that you will have the same cholesterol lowering effect from taking the Lorstat brand as you do from taking the Zarator brand.
Medsafe, the agency that approves medicines for use in New Zealand, carefully considered the safety and effectiveness of Lorstat before approving it.
You shouldn’t notice any difference in how you feel after taking Lorstat. If you do notice any changes or side effects, please talk with your doctor about it.
Will the tablets look different?
Yes. Because Lorstat is made by a different supplier, the tablets will look different to what you are used to.
Will the new brand cost me more?
No. You will pay the usual patient co-payment. There will be no extra cost for you for the Lorstat brand.
Will I still be able to get my current brand after 1 February 2017?
Once the funding for Zarator stops after 1 February 2017, we can’t guarantee it will remain available or how much it will cost.
If you do want to keep using the Zarator brand of atorvastatin you can ask your pharmacist to check the price and availability.
Where can I get more information?
If you would like more information about the change you can contact PHARMAC on firstname.lastname@example.org.
Your doctor, nurse and pharmacist will also help guide you during the changeover period.
Last updated: 26 October 2017